Clinical trial

A Single-Dose Study of MK-8351 in a Lung Allergen Challenge (MK-8351-003)

NCT01926002

Drugs and interventions used in this trial

3 registered

These interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.

Search this trial's interventions

DRUG · Unmapped registry intervention Low-Dose MK-8351 Find medicine records · Find other trials using this name

DRUG · Unmapped registry intervention High-Dose MK-8351 Find medicine records · Find other trials using this name

DRUG · Unmapped registry intervention Placebo to MK-8351 Find medicine records · Find other trials using this name

Study at a glance

Registry-backed

A Single-Dose Study of MK-8351 in a Lung Allergen Challenge (MK-8351-003)

Design: INTERVENTIONAL · Status: WITHDRAWN · Phase: PHASE1

Read study objectives, eligibility and outcome measures at ClinicalTrials.gov

StatusWITHDRAWN

Study typeINTERVENTIONAL

Start date2013-09-01

PhasePHASE1

Conditions

Asthmaverified · MONDO: asthma

Interventions

Low-Dose MK-8351DRUG

High-Dose MK-8351DRUG

Placebo to MK-8351DRUG

Sponsors & collaborators

Merck Sharp & Dohme LLClead sponsor

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT01926002 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.